Cargando…
GABRP promotes CD44s-mediated gemcitabine resistance in pancreatic cancer
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) has the worst five-year overall survival rate among all cancer types. Acquired chemoresistance is considered one of the main reasons for this dismal prognosis, and the mechanism of chemoresistance is unknown. METHODS: We previously identified a sub...
Autores principales: | Chen, Chen, Wu, Binfeng, Wang, Mingge, Chen, Jinghua, Huang, Zhaohui, Shi, Jin-Song |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281597/ https://www.ncbi.nlm.nih.gov/pubmed/35846884 http://dx.doi.org/10.7717/peerj.12728 |
Ejemplares similares
-
The Association of the GABRP Polymorphisms with Systemic Lupus Erythematosus
por: Kim, Hun-Soo, et al.
Publicado: (2015) -
Gemcitabine resistance of pancreatic cancer cells is mediated by IGF1R dependent upregulation of CD44 expression and isoform switching
por: Chen, Chen, et al.
Publicado: (2022) -
Elevated GABRP expression is correlated to the excessive autophagy in intrahepatic cholestasis of pregnancy
por: Dong, Ruihong, et al.
Publicado: (2023) -
GABRP is a potential prognostic biomarker and correlated with immune infiltration and tumor microenvironment in pancreatic cancer
por: Yang, Yihui, et al.
Publicado: (2022) -
Inhibition of Gabrp reduces the differentiation of airway epithelial progenitor cells into goblet cells
por: Wang, An, et al.
Publicado: (2021)